Gut health may boost bone density: probiotic study shows promise
NCT ID NCT06375668
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether taking daily probiotics (Lactobacillus plantarum and Lactobacillus paracasei) for 12 months could improve bone density in postmenopausal women with low bone mass. 170 women participated, taking either the probiotic or a placebo. The goal was to see if these friendly bacteria could help prevent osteoporosis and fractures.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Lactobacillus plantarum and Lactobacillus paracasei probiotics
- What this could lead to
- If it works, this could offer a simple, natural way to help maintain bone density and reduce fracture risk in postmenopausal women.
- What could go wrong
- This is a completed study, but results are not yet widely confirmed. Probiotics may not significantly improve bone density, and individual results can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
170 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Jun 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Postmenopausal women (between 2 and 5 years after their last menstrual period) 2. A dual-energy X-ray absorptiometry (DEXA) scan-based T-score of the lumbar spine (L1-L4) of less than -1.49 (i.e. a normal value according to the World Health Organization) 3. Body mass index (BMI) between 18 and 30 4. Vitamin 25 (OH)D levels between 31-50 ng/mL Exclusion Criteria: 1. The last menstrual period less than 2 or more than 5 years before study recruitment 2. BMI under 18 or above 30 3. Oral or transdermal hormone therapy with estrogens and/or progestogens within the last 6 months 4. Corticosteroid or thyroid hormone therapy within the last 6 months 5. History of osteopenia or osteoporosis 6. Neoplastic disease treated with cytostatic agents within the last 12 months 7. Autoimmune disorders, including rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis; malabsorption syndromes, including celiac disease; chronic kidney disease; chronic liver failure; endocrine disorders, including Hashimoto thyroiditis, Graves' disease, Cushing disease or syndrome, hyperparathyroidism, hypogonadism, hyperprolactinemia, acromegaly, diabetes mellitus; and other chronic conditions affecting bone metabolism 8. Antibiotic therapy within the last 2 months prior to study recruitment 9. Probiotic use within the last 2 months prior to study recruitment 10. Calcium and vitamin D supplementation within the 2 months prior to study recruitment 11. Treatment with antidepressant or antipsychotic agents involving a change of the agents or dosage within the last 3 months 12. Substance use disorder (alcohol, drugs, nicotine) 13. History of organ transplantation 14. Exposure to the SARS-Cov-2 virus within 14 days prior to study recruitment (based on patient declaration) 15. An acute COVID-19 infection within 14 days prior to study recruitment (based on patient declaration) 16. A surgical procedure scheduled to take place during this study 17. Participation in another study within the last 6 months 18. Inability to give an informed consent in writing 19. Any disease or circumstances that, according to the Investigator or Sponsor, might prevent the subject from completing the study or following study procedures and requirements
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bone density, low are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Research Center
Poznan, 60-773, Poland
-
Private Specialist Practice
Bytom, 41-902, Poland
-
Specialist Practice
Katowice, 40-750, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light on bones: laser therapy may boost bone health in postmenopausal women
- Bone drugs may double as liver fat fighters — a trial puts them to the test
- Can a Follow-Up drug keep bones strong after initial osteoporosis therapy?
- Can a single infusion lock in bone gains after osteoporosis treatment?
- Could common statins be a surprise weapon against brittle bones?
- Could adding a second drug boost bone strength in osteoporosis?